Poptika / Shutterstock.com
24 May 2022GeneticsMuireann Bolger
OptraHealth sues Invitae over genetic testing chatbot
OptraHealth has filed a patent infringement lawsuit against Invitae that centres on the latter’s Gia chatbot that offers genetic testing and advice.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
13 May 2021 Generics manufacturer Invitae has filed a lawsuit against rival company Natera claiming that its cancer detection test infringes one of Invitae’s DNA sequencing patents.
Genetics
6 May 2021 The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.
Editor's picks
Editor's picks
Big Pharma
13 May 2021 Generics manufacturer Invitae has filed a lawsuit against rival company Natera claiming that its cancer detection test infringes one of Invitae’s DNA sequencing patents.
Genetics
6 May 2021 The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.
Big Pharma
13 May 2021 Generics manufacturer Invitae has filed a lawsuit against rival company Natera claiming that its cancer detection test infringes one of Invitae’s DNA sequencing patents.
Genetics
6 May 2021 The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.